Back to Results
First PageMeta Content
Lymphocytes / Immunology / T cells / Hematology / Opsoclonus myoclonus syndrome / B-1 cell / Immunophenotyping / CD5 / Paraneoplastic syndrome / Immune system / Biology / Medicine


Movement Disorders Vol. 19, No. 7, 2004, pp. 770 –777 © 2004 Movement Disorder Society CSF B-Cell Expansion in Opsoclonus–Myoclonus Syndrome: A Biomarker of Disease Activity
Add to Reading List

Document Date: 2004-10-07 09:54:23


Open Document

File Size: 96,53 KB

Share Result on Facebook

City

Libertyville / Cary / Miami / Springfield / Marseille / San Jose / St. Louis / /

Company

IgG / SAS Institute Inc. / GE / Wiley InterScience / Pearson / Sperotech Inc. / Research Consulting / /

Country

France / United States / /

/

Facility

SAS Institute / University School / /

IndustryTerm

important clinical tool / thorough search / clinical tool / therapy of childhood opsoclonus-myoclonus syndrome / computer software / /

MedicalCondition

autoimmune movement disorders / myoclonus / Diamond B. Autoimmune diseases / dysarthria / ataxia / mental retardation / unrelated disorders / seizures / opsoclonusmyoclonus syndrome / rheumatoid arthritis / dysfunction / neurological dysfunction / neuroblastoma / Sjo¨gren’s syndrome / treatment decisions Movement Disorders / occult neuroblastoma / Myoclonus Syndrome / multiple sclerosis / chronic phase / occult neuroblastoma using neuroimaging / disorder / Prior neuroblastoma / opsoclonus-myoclonus syndrome / Opsoclonus / illness / ammatory CNS diseases / MS / brain tumors / myasthenia gravis / ataxia / tumor / autoimmune disorders / urine tumor / paraneoplastic syndrome / myoclonic disorders Opsoclonus-myoclonus syndrome / neoplastic disorder / significant tumor / cancer / tumors / disease / neuroblastoma and paraneoplastic opsoclonusmyoclonus / chronic daily headaches / hyperthyroid Grave’s disease / neuroimmunological diseases / unique movement disorder / chronic if / Although tumor / Movement Disorders / embryologically similar neural crest-derived tumors / Kinsbourne M. Myoclonic encephalopathy / identified tumor / Kinsbourne syndrome / substantial CSF leukocytosis / syndrome / disorders / Onset age Syndrome duration category Gender Syndrome / human lupus / /

MedicalTreatment

immunotherapies / chemotherapy / immunotherapy / plasmapheresis / /

NaturalFeature

Kasaian MT / /

Organization

National Pediatric Myoclonus Center / Institutional Review Board / World Health Organization / American Medical Association Research and Education Foundation / Disorders Vol. / Department of Neurology / USA Department of Pediatrics / SIU School of Medicine / SAS Institute / University School of Medicine / Department of Medical Microbiology and Immunology / Southern Illinois University School of Medicine / /

Person

J. Butler / Ann Neurol / N. Burkett / Anna L. Travelstead / Michael R. Pranzatelli / S. Ball / Florence A. Carter / Steven J. Verhulst / /

Position

Prime Minister / anesthesiologist / Fisher / Butler / /

Product

methylprednisolone / dexamethasone / ACTH / corticotropin / propofol / prednisone / /

ProvinceOrState

Illinois / South Dakota / /

RadioStation

Chutorian AM / /

Region

Southern Illinois / /

Technology

Antibodies / laser / chemotherapy / /

SocialTag